These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6194429)

  • 1. Differing reactivities of human and guinea-pig complement on haptenized liposomes via the alternative pathway.
    Okada N; Yasuda T; Tsumita T; Okada H
    Mol Immunol; 1983 Aug; 20(8):857-64. PubMed ID: 6194429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1983 Sep; 50(1):75-84. PubMed ID: 6193057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alternative complement pathway by IgM antibody reacted on paragloboside incorporated into liposome membrane.
    Okada H; Okada N; Yasuda T
    Mol Immunol; 1983 Apr; 20(4):499-500. PubMed ID: 6865961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane sialoglycolipids regulate the activation of alternative complement pathway by liposomes containing trinitrophenylaminocaproyldipalmitoylphosphatidylethaolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1983 Jan; 48(1):129-40. PubMed ID: 6848448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation and inhibition of anti-hapten responses in guinea pigs immunized with hybrid liposomes.
    Kochibe N; Nicolotti RA; Davie JM; Kinsky SC
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4582-6. PubMed ID: 53840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation.
    Okada N; Yasuda T; Okada H
    Biochem Biophys Res Commun; 1988 Mar; 151(2):743-8. PubMed ID: 3348808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunogenic properties of N-substituted phosphatidylethanolamine derivatives and liposomal model membranes.
    Nicolotti RA; Kochibe N; Kinsky SC
    J Immunol; 1976 Nov; 117(5 Pt.2):1898-902. PubMed ID: 62794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of complement activity in human serum using large unilamellar liposomes.
    Masaki T; Okada N; Yasuda R; Okada H
    J Immunol Methods; 1989 Sep; 123(1):19-24. PubMed ID: 2794527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
    Okada N; Yasuda T; Okada H
    J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of nonspecific lysis in liposomal and erythrocyte immunoassay systems by small lipid vesicles and erythrocyte ghosts.
    Schreier H; Valentino K; Heath BP; Kung VT
    Life Sci; 1989; 45(20):1919-30. PubMed ID: 2601559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
    Ho RJ; Huang L
    J Immunol; 1985 Jun; 134(6):4035-40. PubMed ID: 3886794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse monoclonal antibodies at the red cell surface--II. Effect of hapten density on complement fixation and activation.
    Kratz HJ; Borsos T; Isliker H
    Mol Immunol; 1985 Mar; 22(3):229-35. PubMed ID: 4000127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
    Chonn A; Cullis PR; Devine DV
    J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR; Richards RL; Guirguis AA
    J Immunol; 1977 Jan; 118(1):342-7. PubMed ID: 830757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The developoment of total complement activity assay based on complement-dependent immune liposome lysis].
    Skopinskaia SN; Iarkov SP; Khramov EN; Antashev AV
    Vestn Ross Akad Med Nauk; 2014; (3-4):24-30. PubMed ID: 25306592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human factor B activity of the properdin system by human and guinea-pig sera.
    Lambré C
    Ann Immunol (Paris); 1979; 130C(1):71-8. PubMed ID: 373582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.